IP Library Granted Patent US 7,709,655
Granted Patent B2
US 7,709,655 · App. 11/445,464 · Granted May 4, 2010

Clickphosphines for transition metal-catalyzed reactions

Assignee: The Penn State Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,709,655
App. No.
11/445,464
Granted
May 4, 2010
Kind
B2
Abstract

Phosphine triazole ligand compounds, prepared through click chemistry, complex with transition metals to form transition metal-phosphine triazole ligand complexes. These complexes are useful catalysts in coupling reactions such as Suzuki-Miyaura coupling, Stille coupling, Negishi coupling, Sonagashira coupling, carbon-heteroatom bond-forming reactions (C—O and C—N), alpha alkylation of carbonyls, Heck coupling reactions, and hydrogenation reactions.

Claims (20)

1. A phosphine compound selected from the group consisting of one of the following compounds:

wherein where X is hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, ferrocene, silane, hetereoaromatic group, or a substituted alkyl, substituted cylcoalkyl, or substituted aryl moiety having at least one stereogenic center; Y is hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, ferrocene, silane, hetereoaromatic group or a halide such as I, Br, or Cl; and R is an alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, or substituted aryl group.

2. The compound according to claim 1 , wherein R is a t-butyl, cyclohexyl, adamantyl, or phenyl group.

3. The compound according to claim 1 , wherein the phosphine compound comprises structure (I) and wherein X is a phenyl group; Y is a methoxymethylene, phenyl, substituted phenyl or 1-napthylene group; and R is a phenyl, cyclohexyl or t-butyl group.

4. The compound according to claim 3 , wherein the substituted phenyl group is 2-methoxy phenyl, 2,6-dimethyl or 1-napthylene group.

5. The compound according to claim 4 , wherein Y is a phenyl group and R is a cyclohexyl group.

6. The compound according to claim 4 , wherein Y is a phenyl group and R is a t-butyl group.

7. The compound according to claim 4 , wherein Y is a 1-napthyl group and R is a cyclohexyl group.

8. The compound according to claim 4 , wherein Y is a 1-napthyl group and R is a t-butyl group.

9. The compound according to claim 4 , wherein Y is a 2-methoxy phenyl group and R is a cyclohexyl group.

10. The compound according to claim 4 , wherein Y is a 2-methoxy phenyl group and R is a t-butyl group.

11. The compound according to claim 4 , wherein Y is a 2,6-dimethoxy phenyl group and R is a cyclohexyl group.

12. The compound according to claim 4 , wherein Y is a 2,6-dimethoxy phenyl group and R is a t-butyl group.

13. The compound according to claim 4 , wherein Y is a 2,-dimethylamine phenyl group and R is a t-butyl group.

14. The compound according to claim 1 , wherein the phosphine compound comprises structure (II) and R is a phenyl, cyclohexyl or t-butyl group.

15. The compound according to claim 14 , wherein X is hydrogen or a methyl, ethyl, t-butyl, phenyl, 2-methoxyphenyl, 2,6-dimethoxyphenyl, phenylethyl, tosyl or 1-naphthyl group and Y is hydrogen, methoxymethylene, phenyl, 2-methoxyphenyl, 2,6-dimethoxyphenyl, 2-dimethylaminophenyl or 1 naphthyl group.

16. The compound of claim 1 , wherein the compound comprises one of the following structures:

17. The compound of claim 1 , wherein the compound comprises one of the following structures:

18. A racemic bisphosphine and its enantiomer having the following structural formula:

wherein X′ is an alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, ferrocene, silane, hetereoaromatic group, or a substituted alkyl, substituted cylcoalkyl, or substituted aryl moiety having at least one stereogenic center; and R is an alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, or substituted aryl group.

Assignments (3)
CONFIRMATORY LICENSE Recorded Sep 28, 2016
From: PENNSYLVANIA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040166/0620 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Oct 27, 2008
From: THE PENNSYLVANIA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021737/0303 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2006
From: ZHANG, XUMU
To: PENN STATE RESEARCH FOUNDATION, THE
Reel/Frame 018734/0203 →
Continuity (2)
Provisional Application 6068645700 · Jun 2, 2005
Related Publication 20070088166A1 · Apr 19, 2007